The Phillies are keeping their faith in José Alvarado, despite his recent suspension for performance-enhancing drugs. The team exercised Alvarado's $9 million club option for the 2026 season, signaling their confidence in his ability to bounce back. Alvarado, 30, had a mixed year, going 4-2 with a 3.81 ERA in 28 appearances. However, his suspension for 80 games for violating MLB's PED policy was a significant setback. Alvarado's sinker averaged an impressive 99.3 mph from Opening Day to May 16, before his suspension. Despite the suspension, the Phillies believe Alvarado's performance will not be affected, as he took PEDs for weight-loss purposes. Alvarado's velocity and performance are expected to return to normal, and he will join a strong bullpen in 2026, featuring closer Jhoan Duran and left-handers Matt Strahm and Tanner Banks, and right-hander Orion Kerkering. With his elite skills, Alvarado is poised to be a key late-inning reliever when he's healthy.
